Echocardiography as Risk-Assessment for Major Adverse Cardiac Events in Major Vascular Surgery Patients
- Conditions
- Right-Sided Heart FailureLeft-Sided Heart FailureHeart Valve Diseases
- Registration Number
- NCT04836702
- Lead Sponsor
- University of Virginia
- Brief Summary
Patient with coronary artery disease (CAD), heart failure and abnormal heart function undergoing major vascular surgery have a high associated high morbidity and mortality with myocardial infarction accounting for 33-50% of perioperative deaths. The prevalence of CAD in vascular surgery patients approaches 50%. Proper pre-procedure protocols to accurately assess patients and determine who may require further medical optimization prior to undergoing surgery help mitigate risk and improve outcomes. The investigators designed this study as a single center, retrospective cohort analysis to explore the association between ventricular (LV and RV function) and valvular (Aortic / Mitral / Tricuspid) function and expanded major adverse cardiac events (X-MACE).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 813
- Major vascular surgery operation (e.g. CEA, open aortic repair, suprainguinal and infrainguinal bypasses, EVAR, TEVAR) captured in the UVA Vascular Quality Initiative database
- Echocardiography within two years of index operation
- If patient had additional qualifying vascular procedure within 30 days of the index operation, this procedure was excluded
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expanded Major Adverse Cardiac Events In-hospital admission (within 120 days of index surgery) Composite outcome defined as any cardiovascular death, non-fatal MI, non-fatal stroke, post-operative CHF, or new dysrhythmias, all within the index hospital admission.
- Secondary Outcome Measures
Name Time Method